ArticleThe New England journal of medicine2016
Soluble Urokinase Receptor and Chronic Kidney Disease.
Article in The New England journal of medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.Journal of the American Society of Nephrology : JASN · 2018Trial
- The roles of TRPC6 in renal tubular disorders: a narrative review.Renal failure · 2024Review
- Association of suPAR, ST2, and galectin-3 with eGFR decline and mortality in patients with advanced heart failure with reduced ejection fraction.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2024Article
- Up-Date on Diabetic Nephropathy.Life (Basel, Switzerland) · 2022Review
- Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children.Journal of the American Society of Nephrology : JASN · 2020Article
- Identification of dicarbonyl and L-xylulose reductase as a therapeutic target in human chronic kidney disease.JCI insight · 2019Article
- The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.Nature reviews. Nephrology · 2018Review
- Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation.Journal of arrhythmia · 2017Article
- Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells.eLife · 2017Article
Corrections and comments
- Comment on
- Comment on
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
26962914What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.